Found 37 matching trials
Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study. PHASE1 The primary hypothesis is that cancer vaccine can convert non-immunogenic g...
Show More Location
National University Hospital
Learn More & Join Trial
Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma PHASE1 This is a feasibility study in patients with localized or metastatic soft t...
Show More Location
Monter Cancer Center (Northwell Health)
Learn More & Join Trial
A Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic Melanoma PHASE1 The study aims to evaluate the 6 month-treatment tolerance defined as the i...
Show More Learn More & Join Trial
Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab PHASE2 The main goal of this research study is to determine how nivolumab and nivo...
Show More Location
UPMC Hillman Cancer Center
Learn More & Join Trial
A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC) PHASE1 The purpose of this study is to determine whether the combination of a neoa...
Show More Location
Johns Hopkins SKCCC
Learn More & Join Trial
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors PHASE2 This trial was designed to investigate the safety, response rates and survi...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602) PHASE2 This study aims to evaluate the safety, tolerability and effectiveness of n...
Show More Location
Border Medical Oncology
Learn More & Join Trial
Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer PHASE1 This study study aims to elucidate the immune responses to a shared antigen...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
A Phase 2 Trial for Patients With Metastatic Solid Cancer PHASE2 This study seeks to estimate the potential efficacy of the study treatment,...
Show More Location
Ascension Providence Rochester Hospital
Learn More & Join Trial
Clinical Trial of SBRT and Systemic Pembrolizumab With or Without Avelumab/Ipilimumab+ Dendritic Cells in Solid Tumors PHASE2 A randomized phase II clinical trial of SBRT and systemic pembrolizumab wit...
Show More Location
Universitair Ziekenhuis Brussel
Learn More & Join Trial